Wire Stories
Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA� Biosimilar HADLIMA� (adalimumab-bwwd)
INCHEON, Korea & JERSEY CITY, N.J.–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. and Organon & Co. (NYSE: OGN) today announced the U.S. Food and...